Table 3 Surgical procedures and short-term outcomes of stage III disease
|  | EP group (n = 23) | NEP group (n = 25) | p value |
|---|---|---|---|
Type of gastrectomy | 0.246 | ||
 Distal | 11 (47.8) | 12 (48.0) |  |
 Total | 10 (43.5) | 13 (52.0) |  |
 Proximal | 2 (8.7) | 0 |  |
Approach | Â | ||
 Laparoscopic | 5 (21.7) | 6 (24.0) |  |
 Open | 18 (78.3) | 19 (76.0) |  |
Lymphadectomy | Â | ||
  < D2 | 13 (56.5) | 3 (12.0) |  |
 D2 | 10 (43.5) | 22 (88.0) |  |
The numbers of analyzed lymph nodes | 41.1 ± 22.7 | 55.8 ± 22.3 |  |
The numbers of positive lymph nodes | 9.74 ± 9.22 | 13.0 ± 17.6 |  |
Adjuvant chemotherapy | Â | ||
 Present | 7 (30.4) | 20 (80.0) |  |
 Absent | 16 (69.6) | 5 (20.0) |  |
Postoperative complication (CD≥2) |  | ||
 Present | 8 (34.8) | 6 (24.0) |  |
 Absent | 15 (65.2) | 19 (76.0) |  |
Postoperative complication (CD≥3) |  | ||
 Present | 5 (21.7) | 5 (20.0) |  |
 Absent | 18 (78.3) | 20 (80.0) |  |
Death from another disease | Â | ||
 Present | 4 (17.4) | 5 (20.0) |  |
 Absent | 19 (82.6) | 20 (80.0) |  |
Death from primary disease | 0.043 | ||
 Present | 15 (65.2) | 9 (36.0) |  |
 Absent | 8 (34.8) | 16 (64.0) |  |